Role of Janus Kinase inhibitors in the management of pulmonary involvement due to Long COVID-19 disease: A case control study

OBJECTIVES: Ongoing symptomatic coronavirus disease 2019 (OSC) is defined as persistent symptoms beyond 4 weeks of acute illness. OSC leads to prolonged hospitalization and oxygen dependence. We aimed to find the outcome of Janus kinase inhibitors (JAKi) as a steroid-sparing agent to treat OSC. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Pawan Kumar, Sharma, Vinod Kumar, Lalwani, Lokesh Kumar, Chaudhry, Dhruva, Govindagoudar, Manjunath B., Sriram, Chaudhari Pramod, Ahuja, Aman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389097/
https://www.ncbi.nlm.nih.gov/pubmed/37529783
http://dx.doi.org/10.4103/tjem.tjem_363_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389097/
https://www.ncbi.nlm.nih.gov/pubmed/37529783
http://dx.doi.org/10.4103/tjem.tjem_363_22

Ejemplares similares